16:00 – 16:10

Welcome
Pratap Singhasivanon
Faculty of Tropical Medicine, Mahidol University
Bangkok, Thailand

16:10 – 16:20

Opening Remarks
Jose Esparza
Bill & Melinda Gates Foundation
Seattle, WA, USA

16:20 – 16:40

Are There Lessons From Past Vaccines for an AIDS Vaccine
Stanley Plotkin
University of Pennsylvania
Doylestown, PA, USA

16:40 – 17:10

Moving Forward from RV144: An Industrial Perspective
Sanjay Gurunathan
sanofi pasteur
Swiftwater, PA, USA

9:00 – 9:20

Her Royal Highness Princess Maha Chakri Sirinthorn
Bangkok, Thailand

9:20 – 9:50

Progress Towards an HIV Vaccine - Lessons Learned from HIV Prevention
Carl Dieffenbach
Division of AIDS, NIAID, NIH
Bethesda, MD, USA

10:30 – 10:45

Africa's Contribution to AIDS Vaccine Research and Development
Pontiano Kaleebu (bio)
MRC/UVRI Research Unit on AIDS
Entebbe, Uganda

10:45 – 11:00

Thailand's Contribution to HIV Vaccine Research and Development
Punnee Pitisuttithum (bio)
Faculty of Tropical Medicine, Mahidol University
Bangkok, Thailand

11:00 – 11:30

Update on RV144: Correlates, Sieve Analysis, and Clinical Development
Jerome Kim (bio)
Walter Reed Army Institute of Research (WRAIR)
Rockville, MD, USA

11:30 – 12:00

Case Control Study of the RV144 Trial for Immune Correlates: The Analysis and Way Forward
Barton Haynes (bio)
Duke Human Vaccine Institute
Durham, NC, USA

12:00 – 12:20

Poxvirus Vector-Based HIV Vaccine Beyond RV144

Giuseppe Pantaleo (bio)
Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne, Switzerland

12:20 – 12:30

Questions and Answers

08:30 – 09:00

Voluntary Medical Male Circumcision for HIV Prevention: What Are the Lessons for Other Prevention Strategies?

Helen Weiss (bio)
London School of Hygiene & Tropical Medicine
London, United Kingdom

09:00 – 09:30

Lessons Learnt from HIV Pre- And Post-Infection Studies: Implications for Combination Prevention Strategies

Carolyn Williamson (bio)
University of Cape Town
Cape Town, South Africa

09:30 – 10:00

What's New in Preventing Mother-to-Child HIV-1 Transmission (MTCT)
Lynne Mofenson (bio)
National Institute of Child Health and Development, National Institutes of Health
Rockville, MD, USA

11:00 – 11:30

Development of HIV-1 Neutralizing Antibody Vaccines: From Structure to Immunogen Design
Jeffrey Boyington (bio)
Vaccine Research Center, National Institutes of Health
Bethesda, MD, USA

11:30 –12:00

Current Status and Future Directions of Vector Based HIV Vaccines
C. Rick King (bio)
International AIDS Vaccine Initiative
New York, NY, USA

12:00 – 12:30

New Generation of Adjuvants for HIV Vaccines
Steven Reed (bio)
Infectious Disease Research Institute
Seattle, WA, USA

12:30 – 12:35

Pratap Singhasivanon
Faculty of Tropical Medicine, Mahidol University
Bangkok, Thailand

12:35 – 13:00

Dan Barouch
Beth Israel Deaconess Medical Center
Boston, MA, USA